CRIS Projects Details -
Accept Cookies

Cookies: How we use information on our website:

We use cookies on our website to make it clear, useful and reliable. In order to achieve this and to provide certain personalised features we store a small amount
of data about you. Click Here to learn more. By navigating from the front page to other sections of our website, you are consenting to information being stored.


Project Details

 

Investigating clozapine-related blood dyscrasias (neutropenia and agranulocytosis)

Lead Applicant Name :
Hamilton Morrin
Project Type :
Research
Approval Date :
02-May-2024
References :
Lay Summary :
Clozapine is a highly effective medication used for treatment resistant psychosis though can sometimes be associated with side effects of changes in white blood cell levels. Using a technique developed to identify clozapine treatment start dates, we will investigate who develops these changes in white blood cells and the point at which these changes tend to occur during a course of treatment.<br/>